ArticleMolecular neurobiology2021

Evaluation of a Low-Toxicity PARP Inhibitor as a Neuroprotective Agent for Parkinson's Disease.

Laura N Puentes et al.PubMed ↗Publisher ↗

No numbers read from the abstract.